Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture

The emerging SARS-CoV-2 infection associated with the outbreak of viral pneumonia in China is ongoing worldwide. There are no approved antiviral therapies to treat this viral disease. Here we examined the antiviral abilities of three broad-spectrum antiviral compounds gemcitabine, lycorine and oxyso...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ya-Nan, Zhang, Qiu-Yan, Li, Xiao-Dan, Xiong, Jin, Xiao, Shu-Qi, Wang, Zhen, Zhang, Zhe-Rui, Deng, Cheng-Lin, Yang, Xing-Lou, Wei, Hong-Ping, Yuan, Zhi-Ming, Ye, Han-Qing, Zhang, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448857/
https://www.ncbi.nlm.nih.gov/pubmed/32432977
http://dx.doi.org/10.1080/22221751.2020.1772676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448857/
https://www.ncbi.nlm.nih.gov/pubmed/32432977
http://dx.doi.org/10.1080/22221751.2020.1772676

Ejemplares similares